Louis-Philippe Bernier, PhD
Chief Executive Officer at CereCura Nanotherapeutics @ CereCura Nanotherapeutics
About
As a neuroscientist, I have studied CNS diseases at the molecular, cellular and systems levels, striving to improve our understanding of pathological processes to uncover novel pathways amenable to therapeutic targeting. With CereCura, we’re harnessing the power of RNA therapeutics, developing a transformative approach to treat brain diseases. I believe that by optimizing next-generation genetic drug technologies to the unique challenges of the brain, we will find new ways to treat currently untreatable brain diseases.
Canada
Vancouver
Research
Molecular Biology, Neuroscience, Scientific Writing, Cell Culture, Immunology, Western Blotting, Laboratory, Biochemistry, Cell Biology, Electrophysiology, Microbiology, Molecular Cloning, Science, Lifesciences, Fluorescence, Microscopy, Confocal Microscopy, Immunohistochemistry
Experience
Chief Executive Officer at CereCura Nanotherapeutics
CereCura Nanotherapeutics
Vancouver, British Columbia, Canada
CEO & Co-Founder of CereCura Nanotherapeutics, a preclinical stage biotechnology company developing novel RNA therapeutics for central nervous system disorders.
Research Associate
The University of British Columbia
As a senior Research Associate at the UBC Centre for Brain Health, I have been leading research projects in multiple areas of neuroscience. By investigating brain diseases at the molecular, cellular and systems levels, I strive to improve our understanding of pathological processes to uncover novel pathways amenable to therapeutic targeting. I am leading multifaceted projects on neuroinflammation, stroke, neurodegenerative diseases and cerebrovascular regeneration. By adopting a highly collaborative approach to neuroscience, I also participate in team projects on stroke therapy, thrombolytics, epilepsy, Multiple Sclerosis and Alzheimer’s Disease. By studying mechanisms common to many neurological disorders, I believe our work can provide a framework to uncover novel treatment modalities for brain diseases.
Postdoctoral Fellow
The University of British Columbia
Vancouver, BC
Dr. Brian MacVicar's laboratory
Education
McGill University
Neuroscience
Dr Philippe Séguéla's laboratory Study of the intracellular regulation of purinergic receptor channels (P2X) using electrophysiology (patch clamp, two-electrode voltage clamp) and imaging techniques (fluorometric calcium imaging, YO-PRO fluorescence imaging) in various cellular models (Xenopus oocytes, cell lines, primary microglia) along with various molecular biology tools.
Concordia University
Graduate-level business training in Human Ressources Management, Finance, Marketing, Accounting and Organizational Behaviour.
McGill University
Microbiology and Immunology
Major in Microbiology and Immunology, minor in Pharmacolgy
Louis-Philippe Bernier, PhD's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles
Find Emails
Access verified email addresses for your target contacts.
657M+ emails
Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers
More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.